title: Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.
abstract: BACKGROUND
  As a regulator of the penultimate step in the coagulation cascade, thrombin represents a principal target of direct and specific anticoagulants.
  
  
  OBJECTIVE
  A potent thrombin inhibitor complexed with a colloidal nanoparticle was devised as a first-in-class anticoagulant with prolonged and highly localized therapeutic impact conferred by its multivalent thrombin-absorbing particle surface.
  
  
  METHODS
  PPACK (Phe[D]-Pro-Arg-Chloromethylketone) was secured covalently to the surface of perfluorocarbon-core nanoparticle structures. PPACK and PPACK nanoparticle inhibition of thrombin were assessed in vitro via thrombin activity against a chromogenic substrate. In vivo antithrombotic activity of PPACK, heparin, non-functionalized nanoparticles and PPACK nanoparticles was assessed through intravenous (i.v.) administration prior to acute photochemical injury of the common carotid artery. Perfluorocarbon particle retention in extracted carotid arteries from injured mice was assessed via (19) F magnetic resonance spectroscopy (MRS) and imaging (MRI) at 11.7 T. Activated partial thromboplastin time (APTT) measurements determined the systemic effects of the PPACK nanoparticles at various times after injection.
  
  
  RESULTS
  An optical assay verified that PPACK nanoparticles exceeded PPACK's intrinsic activity against thrombin. Application of an in vivo acute arterial thrombosis model demonstrated that PPACK nanoparticles outperformed both heparin (P=0.001) and uncomplexed PPACK (P = 0.0006) in inhibiting thrombosis. (19) F MRS confirmed that PPACK nanoparticles specifically bound to sites of acute thrombotic injury. APTT normalized within 20 min of PPACK nanoparticles injection.
  
  
  CONCLUSIONS
  PPACK nanoparticles present thrombin-inhibiting surfaces at sites of acutely forming thrombi that continue to manifest local clot inhibition even as systemic effects rapidly diminish and thus represent a new platform for localized control of acute thrombosis.
authors: Washington University, Saint Louis, MO, USA.
authors: J
authors: J
authors: Myerson
authors: L
authors: L
authors: He
authors: G
authors: G
authors: Lanza
authors: D
authors: D
authors: Tollefsen
authors: S
authors: S
authors: Wickline
references: Thromb Res. 2008;123 Suppl 1:S2-6
references: 18834617
references: Med Res Rev. 2005 Jan;25(1):66-92
references: 15389730
references: Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2079-93
references: 17600224
references: Cancer Res. 2003 Sep 15;63(18):5838-43
references: 14522907
references: Int Angiol. 2008 Jun;27(3):176-92
references: 18506123
references: Thromb Res. 1979;14(6):969-73
references: 473131
references: Curr Cardiol Rep. 2006 Feb;8(1):65-9
references: 16507239
references: Chest. 2004 Sep;126(3 Suppl):204S-233S
references: 15383473
references: Circulation. 2003 Nov 4;108(18):2270-4
references: 14557370
references: Int J Cancer. 2007 May 1;120(9):1951-7
references: 17278104
references: Cerebrovasc Dis. 2009;27 Suppl 3:12-9
references: 19439936
references: Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1043-54
references: 7849908
references: Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):27-36
references: 17095716
references: Pharmacol Res. 2008 Mar;57(3):171-80
references: 18339557
references: J Am Coll Cardiol. 2009 Dec 1;54(23):2167-73
references: 19942088
references: N Engl J Med. 2008 Aug 28;359(9):938-49
references: 18753650
references: Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):250-7
references: 9484990
references: J Pathol Bacteriol. 1946 Apr;58:207-12
references: 20996420
references: Br J Pharmacol. 2001 Apr;132(7):1441-6
references: 11264237
references: Thromb Haemost. 2003 Oct;90(4):704-9
references: 14515192
references: Mol Aspects Med. 2008 Aug;29(4):203-54
references: 18329094
references: Blood. 2004 Dec 15;104(13):3965-70
references: 15315969
references: Thromb Res. 2008;123(2):288-97
references: 18571697
references: Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9815-9
references: 19487682
references: Protein Sci. 1992 Apr;1(4):426-71
references: 1304349
references: Nature. 2000 Sep 14;407(6801):258-64
references: 11001069
references: Circulation. 2001 Sep 11;104(11):1280-5
references: 11551880
references: J Magn Reson Imaging. 2007 Apr;25(4):667-80
references: 17347992
references: Cardiol Clin. 2008 Nov;26(4):615-28
references: 18929235
references: Circulation. 1992 Jan;85(1 Suppl):I19-24
references: 1728500
references: Invest Radiol. 2000 Apr;35(4):227-34
references: 10764091
references: Clin Pharmacol Ther. 2009 Aug;86(2):139-46
references: 19553932
references: J Lab Clin Med. 1982 Jan;99(1):76-83
references: 7054350
references: Semin Thromb Hemost. 2006 Apr;32 Suppl 1:3-15
references: 16673262